Inactive Instrument

Iomai Corporation Share Price

Stocks

US46202P1030

Pharmaceuticals

End-of-day quote Nasdaq
- - Intraday chart for Iomai Corporation
Manager TitleAgeSince
Corporate Officer/Principal 59 01/12/2015
Director of Finance/CFO 56 -
Corporate Officer/Principal - 01/08/2008
Director TitleAgeSince
Director/Board Member 87 05/07/2006
Director/Board Member 83 01/01/2006
Director/Board Member 73 01/01/2002
Change 5-day change 1-year change 3-year change Capi.($)
+2.06%+3.76%+21.48%-9.59% 6.44TCr
+0.74%+3.52%+51.88%+224.42% 5.61TCr
-3.10%+34.30%+34.30%+34.30% 4.05TCr
-0.65%+0.80%-52.49%-59.12% 3.8TCr
+6.97%+9.89%+71.34%-23.94% 3.19TCr
+12.59%+5.18%+147.68%-45.31% 2.67TCr
+5.78%+15.81%+66.37%+86.63% 2.27TCr
-1.25%-1.31%-2.84%+157.80% 1.67TCr
-0.81%+5.91%+63.81%+123.70% 1.66TCr
Average +2.45%+5.02%+44.61%+54.32% 3.48TCr
Weighted average by Cap. +2.13%+4.57%+39.63%+50.38%
Logo Iomai Corporation
Intercell USA, Inc. provides products for the delivery of vaccines to the skin through a proprietary technology known as transcutaneous immunization, or TCI. The Company is evaluating skin immunization techniques in several human clinical trials, including those to prevent influenza in the healthy adult and elderly populations, and also to prevent travelers' diarrhea and anthrax infection.
Employees
-